Original Research
Published on 13 Apr 2021
MGA Mutation as a Novel Biomarker for Immune Checkpoint Therapies in Non-Squamous Non-Small Cell Lung Cancer
in Pharmacogenetics and Pharmacogenomics

- 5,369 views
- 12 citations
Original Research
Published on 13 Apr 2021
in Pharmacogenetics and Pharmacogenomics
Review
Published on 12 Apr 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 12 Apr 2021
in Pharmacogenetics and Pharmacogenomics
Review
Published on 25 Mar 2021
in Pharmacogenetics and Pharmacogenomics
Opinion
Published on 19 Mar 2021
in Pharmacogenetics and Pharmacogenomics
Technology and Code
Published on 18 Mar 2021
in Pharmacogenetics and Pharmacogenomics
Review
Published on 15 Mar 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 10 Mar 2021
in Pharmacogenetics and Pharmacogenomics
Systematic Review
Published on 08 Mar 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 08 Mar 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 25 Feb 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 24 Feb 2021
in Pharmacogenetics and Pharmacogenomics
General Commentary
Published on 23 Feb 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 16 Feb 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 11 Feb 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 09 Feb 2021
in Pharmacogenetics and Pharmacogenomics